Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab209860-100μg
|
100μg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$109.90
|
|
|
Ab209860-1mg
|
1mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$519.90
|
|
|
Ab209860-5mg
|
5mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,299.90
|
|
|
Ab209860-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,079.90
|
|
Purity≥95% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG2SA; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
| Product Name | Hanwha patent anti-VCAM-1 (anti-VCAM1) - Primary antibody, specific to VCAM1, Human IgG2SA |
|---|---|
| Synonyms | CD106 antibodyCD106 Antigen antibody | INCAM 100 antibody | INCAM-100 antibody | L1CAM antibody | MGC99561 antibody | V-CAM 1 antibody | Vascular Cell Adhesion Molecule 1 antibody | Vascular cell adhesion protein 1 antibody | VCAM 1 antibody | VCAM-1 anti |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Biochemical and Physiological Mechanisms | Important in cell-cell recognition. Appears to function in leukocyte-endothelial cell adhesion. Interacts with the beta-1 integrin VLA4 on leukocytes, and mediates both adhesion and signal transduction. The VCAM1/VLA4 interaction may play a pathophysiolog |
| Host species | Human |
| Specificity | VCAM1 |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Product Description |
Hanwha patent anti-VCAM-1 (anti-VCAM1) is a conjugated liposome targeting vascular cell adhesion molecule (VCAM)-1. It serves as a drug delivery system with dual functions: targeted delivery and solubilizing capacity. |
| Isotype | Human IgG2SA |
|---|---|
| Light Chain Type | lambda |
| SDS-PAGE | 143.4 kDa |
| Purification Method | Protein A purified |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Hanwha patent anti-VCAM-1 (anti-VCAM1) (Ab209860) - Flow Cytometry
Flow Cytometry analysis of K562 cells labelling VCAM1 (red) with Hanwha patent anti-VCAM-1 (anti-VCAM1) (Ab209860) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Hanwha patent anti-VCAM-1 (anti-VCAM1) (Ab209860) - Flow Cytometry
Flow Cytometry analysis of CaKi-1 cells labelling VCAM1 at 1×105 cell/well can bind Hanwha patent anti-VCAM-1 (anti-VCAM1) (Ab209860).
Hanwha patent anti-VCAM-1 (anti-VCAM1) (Ab209860) - ELISA
Immobilized Recombinant Human VCAM1 protein (rp169680) at 1.0 μg/mL can bind Hanwha patent anti-VCAM-1 (anti-VCAM1) (Ab209860) with the EC50 of 33.13 ng/mL.
Hanwha patent anti-VCAM-1 (anti-VCAM1) (Ab209860) - SEC
The purity of Hanwha patent anti-VCAM-1 (anti-VCAM1) (Ab209860) is more than 95% verified by HPLC.